checkpoint inhibitors Archives - Page 18 of 25

Meet CRI’s New CEO Alicia Zhou, PhD

Why CRI
- Our Purpose
- Our Approach
- Our Leadership
- About CRI
- Resources
  - Events
  - Blog
  - Media Room
  - Annual Reports
  - FAQs
This is your opportunity to help create a world immune to cancer

Join us and the world’s leading scientists in the pursuit of life saving immunotherapies that will forever change how we treat cancer, from the inside out.

DONATE NOW
Immunotherapy
- Overview
  - Immunotherapy at a Glance
  - Immunotherapy In-Depth
- Resource Center
- Immunotherapy Stories
  - Patients
This is your opportunity to help create a world immune to cancer

Join us and the world’s leading scientists in the pursuit of life saving immunotherapies that will forever change how we treat cancer, from the inside out.

DONATE NOW
Who We Serve
- Scientists
- Patients
This is your opportunity to help create a world immune to cancer

Join us and the world’s leading scientists in the pursuit of life saving immunotherapies that will forever change how we treat cancer, from the inside out.

DONATE NOW
Take Action
- Donate
- Fundraise
- Participate
- Become a Partner
This is your opportunity to help create a world immune to cancer

Join us and the world’s leading scientists in the pursuit of life saving immunotherapies that will forever change how we treat cancer, from the inside out.

DONATE NOW

Why CRI
- Our Purpose
- Our Approach
- Our Leadership
- About CRI
- Resources
  - Events
  - Blog
  - Media Room
  - Annual Reports
  - FAQs
This is your opportunity to help create a world immune to cancer

Join us and the world’s leading scientists in the pursuit of life saving immunotherapies that will forever change how we treat cancer, from the inside out.

DONATE NOW
Immunotherapy
- Overview
  - Immunotherapy at a Glance
  - Immunotherapy In-Depth
- Resource Center
- Immunotherapy Stories
  - Patients
This is your opportunity to help create a world immune to cancer

Join us and the world’s leading scientists in the pursuit of life saving immunotherapies that will forever change how we treat cancer, from the inside out.

DONATE NOW
Who We Serve
- Scientists
- Patients
This is your opportunity to help create a world immune to cancer

Join us and the world’s leading scientists in the pursuit of life saving immunotherapies that will forever change how we treat cancer, from the inside out.

DONATE NOW
Take Action
- Donate
- Fundraise
- Participate
- Become a Partner
This is your opportunity to help create a world immune to cancer

Join us and the world’s leading scientists in the pursuit of life saving immunotherapies that will forever change how we treat cancer, from the inside out.

DONATE NOW

Filter stories by:

Durvalumab Becomes First Immunotherapy Approved for Stage III Lung Cancer

February 20, 2018December 14, 2022 Arthur N. Brodsky, PhD

2018 Immuno-Oncology 360° Conference

February 12, 2018December 14, 2022 Arthur N. Brodsky, PhD

How Man’s Best Friend Could Help Us Cure Cancer

January 22, 2018December 14, 2022 Arthur N. Brodsky, PhD

Looking Back at 2017’s Immunotherapy Breakthroughs

December 28, 2017December 14, 2022 Arthur N. Brodsky, PhD

Advances in Personalized Approaches Against Cancer

December 22, 2017December 14, 2022 Arthur N. Brodsky, PhD

CRI Researcher Highlights New Technique to Aid Immunotherapy

October 26, 2017December 14, 2022 Arthur N. Brodsky, PhD

1 … 16 17 18 19 20 … 25

This website uses tracking technologies, such as cookies, to provide a better user experience. If you continue to use this site, then you acknowledge our use of tracking technologies. For additional information, review our Privacy Policy.